BioCentury
ARTICLE | Management Tracks

CFO Jeff Trigilio leaves Cullinan

Plus: CFO Bo Kruse resigns at Y-mAbs, and updates from Endeavor, Nuclera and 4P-Pharma

March 15, 2024 1:23 AM UTC

Cullinan Oncology Inc. (NASDAQ:CGEM) said CFO Jeff Trigilio, who helped take the company public in a January 2021 IPO, will leave the organization on March 29. While Cullinan searches for a permanent replacement, VP and Controller Nate Nguyen will be its interim principal financial and accounting officer. Nguyen joined the company in early 2021, and was promoted to his current role in July 2022.

Y-mAbs Therapeutics Inc. (NASDAQ:YMAB) is looking for a new CFO following the resignation of Bo Kruse, who will become a non-executive employee once his successor has joined the company, and then a non-employee consultant for an undisclosed period of time beginning on July 31. Kruse became CFO of Y-mAbs in 2015. ...